drugset / Trial / NCT02517099
Preschool Wheeze: Inflammation/Infection Guided Management
Phase 2
Completed
60 enrolled
Imperial College London
National Institute for Health Research, United Kingdom · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a single-centre, randomised-controlled trial, comparing management of preschool wheeze. It specifically aims to compare management of preschool wheeze using current clinical guidelines to management determined by eosinophilic inflammation and infection. Participants will be children aged 1-5 years who have recurrent wheezing and will be allocated to one of two treatment groups, either current clinical care or pathological phenotype based management. They will be asked to make 2 study visits to the Royal Brompton Hospital over the course of 4 months.
Timeline
- Start
- 2015-06-05
- Primary completion
- 2018-08-17
- Completion
- 2018-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 0.3 unknown | — |
| Comparator | Azithromycin | Small molecule | 10 mg/kg | — |
| Comparator | Beclomethasone | Small molecule | 200 ug | Inhaled |